{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:54:41Z","timestamp":1790934881809,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06281-3","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:30Z","timestamp":1786982610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low albumin-to-globulin ratio is associated with interstitial lung disease in primary Sj\u00f6gren's syndrome: a single-center retrospective cohort study with propensity score matching"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-8558","authenticated-orcid":false,"given":"Jianbin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0808-098X","authenticated-orcid":false,"given":"Suiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9959-6340","authenticated-orcid":false,"given":"Yuzhen","family":"Gesang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9906-5911","authenticated-orcid":false,"given":"Wenwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-0966","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"3","key":"6281_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon M, McCoy S, Nguyen Y et al (2024) Epidemiology of Sj\u00f6gren syndrome. Nat Rev Rheumatol 20(3):158\u2013169. https:\/\/doi.org\/10.1038\/s41584-023-01057-6","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"6281_CR2","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.55563\/clinexprheumatol\/255qsx","volume":"41","author":"S Longhino","year":"2023","unstructured":"Longhino S, Chatzis LG, Dal Pozzolo R et al (2023) Sj\u00f6gren\u2019s syndrome: one year in review 2023. Clin Exp Rheumatol 41(12):2343\u20132356. https:\/\/doi.org\/10.55563\/clinexprheumatol\/255qsx","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"6281_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/1756-185X.13881","volume":"23","author":"C He","year":"2020","unstructured":"He C, Chen Z, Liu S et al (2020) Prevalence and risk factors of interstitial lung disease in patients with primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Int J Rheum Dis 23(8):1009\u20131018. https:\/\/doi.org\/10.1111\/1756-185X.13881","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"6281_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92024-2","volume":"11","author":"YJ Kim","year":"2021","unstructured":"Kim YJ, Choe J, Kim HJ et al (2021) Long-term clinical course and outcome in patients with primary Sj\u00f6gren syndrome-associated interstitial lung disease. Sci Rep 11(1):12827. https:\/\/doi.org\/10.1038\/s41598-021-92024-2","journal-title":"Sci Rep"},{"issue":"1","key":"6281_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10067-024-07191-0","volume":"44","author":"R Pang","year":"2025","unstructured":"Pang R, Ma X, Guo H, Qi X (2025) Meta-analysis of mortality-associated factors in primary Sj\u00f6gren\u2019s syndrome patients with interstitial lung disease. Clin Rheumatol 44(1):23\u201331. https:\/\/doi.org\/10.1007\/s10067-024-07191-0","journal-title":"Clin Rheumatol"},{"issue":"2","key":"6281_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.chest.2020.10.011","volume":"159","author":"AS Lee","year":"2021","unstructured":"Lee AS, Scofield RH, Hammitt KM et al (2021) Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren\u2019s. Chest 159(2):683\u2013698. https:\/\/doi.org\/10.1016\/j.chest.2020.10.011","journal-title":"Chest"},{"issue":"15","key":"6281_CR7","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2147\/JIR.S347161","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li C, Wang W et al (2022) serum albumin to globulin ratio is associated with the presence and severity of inflammatory bowel disease. J Inflamm Res 14(15):1907\u20131920. https:\/\/doi.org\/10.2147\/JIR.S347161","journal-title":"J Inflamm Res"},{"issue":"6","key":"6281_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448\u2013454. https:\/\/doi.org\/10.1056\/NEJM199902113400607","journal-title":"N Engl J Med"},{"issue":"1","key":"6281_CR9","first-page":"105","volume":"71","author":"TX O'Connell","year":"2005","unstructured":"O\u2019Connell TX, Horita TJ, Kasravi B (2005) Understanding and interpreting serum protein electrophoresis. Am Fam Physician 71(1):105\u2013112","journal-title":"Am Fam Physician"},{"issue":"19","key":"6281_CR10","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.7150\/jca.21141","volume":"8","author":"J He","year":"2017","unstructured":"He J, Pan H, Liang W et al (2017) Prognostic effect of albumin-to-globulin ratio in patients with solid tumors: a systematic review and meta-analysis. J Cancer 8(19):4002\u20134010. https:\/\/doi.org\/10.7150\/jca.21141","journal-title":"J Cancer"},{"issue":"1","key":"6281_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-1707-1","volume":"21","author":"F Peng","year":"2020","unstructured":"Peng F, Sun L, Chen T et al (2020) Albumin-globulin ratio and mortality in patients on peritoneal dialysis: a retrospective study. BMC Nephrol 21(1):51. https:\/\/doi.org\/10.1186\/s12882-020-1707-1","journal-title":"BMC Nephrol"},{"issue":"4","key":"6281_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/03000605241244761","volume":"52","author":"M Liu","year":"2024","unstructured":"Liu M, Li X, Huang Y et al (2024) Albumin to globulin ratio (AGR) in systemic lupus erythematosus: correlation with disease activity. J Int Med Res 52(4):03000605241244761. https:\/\/doi.org\/10.1177\/03000605241244761","journal-title":"J Int Med Res"},{"issue":"10","key":"6281_CR13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.94377","volume":"17","author":"V Rabrenovic","year":"2025","unstructured":"Rabrenovic V, Rabrenovic M, Petrovic M, Pilcevic D, Labovic B, Rancic N (2025) The significance of newly derived disease activity parameters neutrophil\/albumin ratio, neutrophil\/complement C3 ratio, and albumin\/globulin ratio in a group of patients with lupus nephritis. Cureus 17(10):e94377. https:\/\/doi.org\/10.7759\/cureus.94377","journal-title":"Cureus"},{"issue":"3","key":"6281_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne G, Mariette X (2018) B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 14(3):133\u2013145. https:\/\/doi.org\/10.1038\/nrrheum.2018.1","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6281_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017) American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6281_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"6281_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786","journal-title":"Multivariate Behav Res"},{"issue":"4","key":"6281_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P (2017) Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 167(4):268\u2013274. https:\/\/doi.org\/10.7326\/M16-2607","journal-title":"Ann Intern Med"},{"key":"6281_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684999","volume":"12","author":"W Du","year":"2021","unstructured":"Du W, Han M, Zhu X et al (2021) The multiple roles of B cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Front Immunol 12:684999. https:\/\/doi.org\/10.3389\/fimmu.2021.684999","journal-title":"Front Immunol"},{"issue":"4","key":"6281_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10040503","volume":"10","author":"F Tabata","year":"2021","unstructured":"Tabata F, Wada Y, Kawakami S et al (2021) Serum albumin redox states: more than oxidative stress biomarker. Antioxidants (Basel) 10(4):503. https:\/\/doi.org\/10.3390\/antiox10040503","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"6281_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/cphy.c190017","volume":"10","author":"E Otoupalova","year":"2020","unstructured":"Otoupalova E, Smith S, Cheng G et al (2020) Oxidative stress in pulmonary fibrosis. Compr Physiol 10(2):509\u2013547. https:\/\/doi.org\/10.1002\/cphy.c190017","journal-title":"Compr Physiol"},{"issue":"1","key":"6281_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02562-w","volume":"23","author":"YH Chen","year":"2023","unstructured":"Chen YH, Lee TJ, Hsieh HJ, Hsieh SC, Wang HC, Chang YC, Yu CJ, Chien JY (2023) Clinical outcomes and risk factors of progressive pulmonary fibrosis in primary Sj\u00f6gren\u2019s syndrome-associated interstitial lung disease. BMC Pulm Med 23(1):268. https:\/\/doi.org\/10.1186\/s12890-023-02562-w","journal-title":"BMC Pulm Med"},{"issue":"8","key":"6281_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini C, Fulvio G, La Rocca G et al (2024) Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 20(8):473\u2013491. https:\/\/doi.org\/10.1038\/s41584-024-01135-3","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"6281_CR24","first-page":"102","volume":"112","author":"P Brito-Zer\u00f3n","year":"2018","unstructured":"Brito-Zer\u00f3n P, Acar-Denizli N, Ng WF et al (2018) How immunological profile drives clinical phenotype of primary Sj\u00f6gren\u2019s syndrome at diagnosis: analysis of 10,500 patients (Sj\u00f6gren Big Data Project). Clin Exp Rheumatol 112(3):102\u2013112","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"6281_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/rheumatology\/keaa367","volume":"60","author":"GE Thorlacius","year":"2021","unstructured":"Thorlacius GE, Hultin-Rosenberg L, Sandling JK et al (2021) Genetic and clinical basis for two distinct subtypes of primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 60(2):837\u2013848. https:\/\/doi.org\/10.1093\/rheumatology\/keaa367","journal-title":"Rheumatology (Oxford)"},{"issue":"16","key":"6281_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164963","volume":"13","author":"G La Rocca","year":"2024","unstructured":"La Rocca G, Ferro F, Sambataro G, Elefante E, Fulvio G, Navarro IC, Moretti M, Romei C, Mosca M, Baldini C (2024) Interstitial lung disease phenotypes and predictive risk factors in primary Sj\u00f6gren\u2019s syndrome. J Clin Med 13(16):4963. https:\/\/doi.org\/10.3390\/jcm13164963","journal-title":"J Clin Med"},{"issue":"1","key":"6281_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35608-4","volume":"13","author":"KA Lee","year":"2023","unstructured":"Lee KA, Nam BD, Hwang JH, Kim HS (2023) Clinical course and risk factors for development and progression of interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome. Sci Rep 13(1):9189. https:\/\/doi.org\/10.1038\/s41598-023-35608-4","journal-title":"Sci Rep"},{"issue":"2","key":"6281_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00296-021-04970-9","volume":"42","author":"L Qin","year":"2022","unstructured":"Qin L, Zhang Y, Yang X et al (2022) Cardiac involvement in primary Sj\u04e7gren\u2019s syndrome. Rheumatol Int 42(2):179\u2013189. https:\/\/doi.org\/10.1007\/s00296-021-04970-9","journal-title":"Rheumatol Int"},{"issue":"8","key":"6281_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00296-020-04543-2","volume":"40","author":"M Jask\u00f3lska","year":"2020","unstructured":"Jask\u00f3lska M, Chyli\u0144ska M, Masiak A et al (2020) Peripheral neuropathy and health-related quality of life in patients with primary Sj\u00f6gren\u2019s syndrome: a preliminary report. Rheumatol Int 40(8):1267\u20131274. https:\/\/doi.org\/10.1007\/s00296-020-04543-2","journal-title":"Rheumatol Int"},{"issue":"11","key":"6281_CR30","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00296-023-05386-3","volume":"43","author":"M Mayer","year":"2023","unstructured":"Mayer M, Martinic M, Reihl-Crnogaj M et al (2023) The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sj\u00f6gren\u2019s syndrome: a single-centre, retrospective cohort study. Rheumatol Int 43(11):2031\u20132036. https:\/\/doi.org\/10.1007\/s00296-023-05386-3","journal-title":"Rheumatol Int"},{"key":"6281_CR31","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.2147\/RMHP.S533705","volume":"18","author":"J Diao","year":"2025","unstructured":"Diao J, Qiao L, Duan X, Hui M, Li M, Zhao Y, Zeng X, Xu D (2025) Clinical characteristics and risk factors for progressive pulmonary fibrosis in primary Sj\u00f6gren\u2019s syndrome: a case-control study. Risk Manag Healthc Policy 18:3017\u20133028. https:\/\/doi.org\/10.2147\/RMHP.S533705","journal-title":"Risk Manag Healthc Policy"},{"issue":"7","key":"6281_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14070708","volume":"14","author":"A Manfredi","year":"2024","unstructured":"Manfredi A, Sambataro G, Rai A, Cerri S, Sambataro D, Vacchi C, Cassone G, Vancheri C, Sebastiani M (2024) Prevalence of progressive fibrosing interstitial lung disease in patients with primary Sj\u00f6gren syndrome. J Pers Med 14(7):708. https:\/\/doi.org\/10.3390\/jpm14070708","journal-title":"J Pers Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06281-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06281-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06281-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:10:02Z","timestamp":1790932202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06281-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6281"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06281-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (approval number: TYLL2026[K]No.027; approval date: February 13, 2026), and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the retrospective design and full de-identification of all patient data, the requirement for written informed consent was waived by the Ethics Committee of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors used OpenAI's GPT-4o (a large language model developed by OpenAI;\n                      \n                      ) solely for English language polishing and grammar refinement during the preparation of this manuscript. AI was used between March 2026 and May 2026 (specifically: initial language polishing of the first draft was performed in March\u2013April 2026; further language refinements to the revised manuscript were performed in May 2026; and final language polishing of this revision was performed in May\u2013June 2026). AI was not used to generate scientific content, study design, statistical analyses, results, interpretations, conclusions, or references. All AI-suggested language edits were carefully reviewed, verified, and revised by the authors, who take full responsibility for the originality, accuracy, and integrity of the manuscript content. The authors confirm compliance with the COPE and ICMJE guidance on the ethical use of AI in scholarly publishing.","order":4,"name":"Ethics","label":"Use of artificial intelligence","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"241"}}